Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Jinhai International Group Holdings Limited ( (HK:2225) ).
Jinhai Medical Technology Limited has announced a change in its principal place of business in Hong Kong, effective from November 19, 2025. The relocation to Chinachem Century Tower in Wanchai signifies a strategic move that could enhance its operational efficiency and market positioning within the region.
The most recent analyst rating on (HK:2225) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Jinhai International Group Holdings Limited stock, see the HK:2225 Stock Forecast page.
More about Jinhai International Group Holdings Limited
Jinhai Medical Technology Limited is a company incorporated in the Cayman Islands, operating within the medical technology industry. It focuses on providing medical products and services, with a market presence in Hong Kong.
Average Trading Volume: 11,440,951
Technical Sentiment Signal: Buy
Current Market Cap: HK$6.98B
Find detailed analytics on 2225 stock on TipRanks’ Stock Analysis page.